Tuesday, 21 May 2024

CEPI & GHIC collaborate to advance vaccine R&D for emerging infectious diseases

24 April 2023 | News

To accelerate the development of medical countermeasures

image credit- shutterstock

image credit- shutterstock

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and US-headquartered Global Health Investment Corporation (GHIC) have signed a Memorandum of Understanding (MoU) to enhance cooperation between the two organizations in the fields of vaccine research, development, manufacturing and stockpiling.

CEPI and GHIC have complementary mandates focused on accelerating the development and enabling equitable access to medical countermeasures against epidemic and pandemic threats. This new collaboration will support both organisations to deliver on their respective missions by fostering closer scientific and technical cooperation between the partners in pursuit of their common goals.

The partners will share information and expertise relevant to medical countermeasures with the potential to address emerging infectious disease threats and public health emergencies. They will also pursue opportunities for practical cooperation including strengthening both organizations’ investment portfolios by jointly identifying – and potentially jointly funding – promising vaccine development platforms and technologies for the benefit of global health, including vaccine R&D for priority pathogens and virus families of mutual interest.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account